CN1067571C - Chinese medicine capsule for treating lumbar and cervical protrusion - Google Patents
Chinese medicine capsule for treating lumbar and cervical protrusion Download PDFInfo
- Publication number
- CN1067571C CN1067571C CN98101748A CN98101748A CN1067571C CN 1067571 C CN1067571 C CN 1067571C CN 98101748 A CN98101748 A CN 98101748A CN 98101748 A CN98101748 A CN 98101748A CN 1067571 C CN1067571 C CN 1067571C
- Authority
- CN
- China
- Prior art keywords
- radix
- capsule
- root
- cervical
- lumbar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a capsule for treating prolapse of lumbar intervertebral disc and herniation of cervical disc, which is called as a capsule for treating lumbar and cervical protrusion. The capsule is prepared by mixing and purifying pure traditional Chinese medicines to obtain powder, and preparing the powder into a capsule, wherein the pure traditional Chinese medicines comprise components of the following weight percentage: 4 to 5 of garter snake, 4 to 5 of doubleteeth pubesscent angelica root, 4 to 5 of pawpaw, 4 to 5 of twotoothed achyranthes root, 4 to 5 of hemlock parsley, 8 to 10 of eucommia bark, 8 to 10 of cibot rhizome, 8 to 10 of prepared rhizome of rehmannia, 8 to 10 of milkvetch root, 8 to 10 of suberect spatholobus, 2.5 to 3.5 of stir-baked olibanum, 2.5 to 3.5 of stir-baked myrrh, 2.5 to 3.5 of stiff silkorm, 2.5 to 3.5 of prepared liauorice root, 2.5 to 3.5 of centipede, 0.8 to 1.5 of wild ginger and 13 to 15 of white peony alba. The capsule has the advantages of appropriate prescription, reasonable dose, treatment of both manifestation and root cause of diseases, patients without pain, no toxic or side effect, high cure rate, etc.
Description
The present invention relates to a kind of treatment lumbar and cervical protrusion Chinese medicinal capsule for the treatment of prolapse of lumbar intervertebral disc, prolapse of cervical intervertebral disc, belong to a kind of Chinese patent medicine.
Prolapse of lumbar intervertebral disc and prolapse of cervical intervertebral disc are common disease and multiple disease.The disease of this class of treatment adopts operative treatments more at present, medicine dissolution, methods such as oral YAOTONGNING class medicine and local traction, lumbago caused or sciatica such as operative treatment part patient Yi Fufa and concurrent articuli intervertebrales inflammation, lumbar instability, adhesion and cicatrix etc. are so operative therapy generally is difficult for adopting; The medicine dissolution method needs anesthesia, the operation sequence complexity, and patient is painful big, accidental complication, therefore also seldom adopt, simple traction also can the respite symptom to small number of patients, but to reduce because of the inflammation edematous condition effect of intervertebral disk hernia compressing local nerve root little.Mostly oral YAOTONGNING class medicine is that to take stopgap measures be basis, and certain toxic and side effects is arranged, and symptom very easily recurs after the drug withdrawal, can not fully recover.
The objective of the invention is to overcome the weak point in the background technology and provide a kind of promptly take stopgap measures effect a permanent cure, have no side effect, patient's no pain, the higher treatment lumbar and cervical protrusion Chinese medicinal capsule of cure rate.
The object of the present invention is achieved like this: it be select for use pure Chinese medicine to be mixed in proportion to be purified to powder encapsulated, every 0.5g, component and percentage by weight are Zaocys, Radix Angelicae Pubescentis, Fructus Chaenomelis, Radix Achyranthis Bidentatae, each 4-5 of Rhizoma Chuanxiong, the Cortex Eucommiae, Rhizoma Cibotii, Radix Rehmanniae Preparata, the Radix Astragali, each 8-10 of Caulis Spatholobi, Olibanum (parched), Myrrha (parched), Bombyx Batryticatus, Radix Glycyrrhizae Preparata, each 2.5-3.5 of Scolopendra, Herba Asari 0.8~1.5, Radix Paeoniae Alba 13-15, its each raw material weight percentage ratio is: Zaocys, Radix Angelicae Pubescentis, Fructus Chaenomelis, Radix Achyranthis Bidentatae, Rhizoma Chuanxiong each 4.6, the Cortex Eucommiae, Rhizoma Cibotii, Radix Rehmanniae Preparata, the Radix Astragali, Caulis Spatholobi each 9.3, Olibanum (parched), Myrrha (parched), Bombyx Batryticatus, Radix Glycyrrhizae Preparata, Scolopendra each 3.1, Herba Asari 1.2, the Radix Paeoniae Alba 13.8.
Pharmacology: the Cortex Eucommiae, Rhizoma Cibotii, Radix Rehmanniae Preparata have invigorating the liver and kidney, bone and muscle strengthening, strong waist knee joint effect; Radix Achyranthis Bidentatae, Rhizoma Chuanxiong, Zaocys, Olibanum (parched), Myrrha (parched), Fructus Chaenomelis have blood-activating and qi-promoting, detumescence and promoting granulation, wind-expelling pain-stopping effect; The Radix Astragali has the effect that QI invigorating is given birth to sun, diuretic detumescent; Caulis Spatholobi, Bombyx Batryticatus, Scolopendra, Herba Asari have collateral dredging, the effect of expelling wind and cold analgesic; The Radix Paeoniae Alba can yin nourishing be held back sun; Radix Glycyrrhizae has the effect of coordinating the actions of various ingredients in a prescription, all medicines with become after have invigorating the kidney and strengthening the bones, promoting blood circulation to remove obstruction in the collateral, expelling wind and cold, reducing swelling and alleviating pain, improve spinal nerve root and local organization edema etc., with reach neck, waist that treatment causes because of lumbar and cervical protrusion of intervertebral disc disease, pain, numbness have a pain in the leg, limb activity is limited to be waited the nerve root compression symptom and firm cervical vertebra, lumbar vertebra, the function of a piece of wood serving as a brake to halt a carriage band, muscle normal function is on every side arranged, thereby reaches the effect of promptly taking stopgap measures and effecting a permanent cure.
The present invention compared with prior art has following advantage:
1, promptly takes stopgap measures and effect a permanent cure, follow up a case by regular visits to and do not find rebound phenomenon;
2, component uniqueness, reasonable mixture ratio has the merit of invigorating the kidney and strengthening the bones, promoting blood circulation to remove obstruction in the collateral, expelling wind and cold, reducing swelling and alleviating pain
Imitate taking convenience, patient's no pain;
3, have no side effect, identify all nontoxic level and do not have cumulative toxicity through anxious, slow toxicity;
4, total effective rate height, example is observed the statistics total effective rate and is reached 95.7%, cure rate 62% surplus clinical 1000.
Model case:
Example 1, Xiao * *, woman, 46 years old, Hao Ge people from village, Zunhua City, Hebei province.
Main cause: lumbago and skelalgia half a year, the limitation of activity of waist and lower limb, once repeatedly the hospitalize of several families was invalid in this locality.On August 12nd, 1996, lift into my institute's clinic with stretcher.Check: lumbar vertebra 4~5 joints, waist 5~sacrum 1 joint supraspinal ligament tenderness is obvious, and other the withholding of vertebra levied the positive, and be obvious with the right side, and right side straight-leg raising test and reinforcement test are positive.Waist CT: waist 4-5, waist 5-sacrum 1, vertebra news dish are outstanding to the right, the compressing spinal nerve root.
Diagnosis: prolapse of lumbar intervertebral disc.Income is in hospital.
Treatment: main oral medication lumbar and cervical protrusion Chinese medicinal capsule, one time 5, three times on the one, cooperate complementary therapies such as pelvic traction.Remission in 3 days, own walking in 7 days is left hospital, band medicine 45 staggering amounts, clothes certainly.Follow up a case by regular visits to not recurrence so far, and do general housework and slight field labour.
Example 2, Korea Spro * *, man, 48 years old, the cement plant workman of Yutian County, Hebei province, suffer from prolapse of lumbar intervertebral disc for many years, it is invalid to seek medical advice in many ways, comes my gate to examine on March 6th, 1997 and seeks medical advice, through inspections such as CT, be diagnosed as prolapse of lumbar intervertebral disc, out-patient treatment, oral medication lumbar and cervical protrusion Chinese medicinal capsule.(one a month) remission course of treatment, the activity of waist lower limb freely, clinical cure is followed up a case by regular visits to so far recurrence.
Example 3, congratulate * *, the man, 58 years old, one engineer of company of group was built in Tangshan.Main cause: cervical pain, limitation of activity. examine on June 3rd, 1996, through the X-ray sheet, the CT sheet is diagnosed as prolapse of cervical intervertebral disc, cervical spondylosis etc.Oral administration treatment lumbar and cervical protrusion Chinese medicinal capsule two months, remission, clinical cure is followed up a case by regular visits to so far not recurrence.
Below in conjunction with embodiment in detail the present invention is described in detail: select for use pure Chinese medicine to mix in following ratio and purify, concentrate and make powder, every 100Kg can be purified to the 8-10Kg powder, encapsulated making, every 0.5g.
Composition and proportioning see the following form:
Instructions of taking: three times on the one, each 5, one month is a course of treatment, and general 2-3 can cure the course of treatment.
Claims (2)
1, a kind of treatment lumbar and cervical protrusion Chinese medicinal capsule, it is characterized in that it is to be mixed by the raw material of Chinese medicine of following percentage by weight to be purified to that powder is encapsulated to form: Zaocys, Radix Angelicae Pubescentis, Fructus Chaenomelis, Radix Achyranthis Bidentatae, each 4-5 of Rhizoma Chuanxiong, the Cortex Eucommiae, Rhizoma Cibotii, Radix Rehmanniae Preparata, the Radix Astragali, each 8-10 of Caulis Spatholobi, Olibanum (parched), Myrrha (parched), Bombyx Batryticatus, Radix Glycyrrhizae Preparata, each 2.5-3.5 of Scolopendra, Herba Asari 0.8-1.5, Radix Paeoniae Alba 13-15.
2, treatment lumbar and cervical protrusion Chinese medicinal capsule according to claim 1, the percentage by weight that it is characterized in that each raw material is: Zaocys, Radix Angelicae Pubescentis, Fructus Chaenomelis, Radix Achyranthis Bidentatae, Rhizoma Chuanxiong each 4.6, the Cortex Eucommiae, Rhizoma Cibotii, Radix Rehmanniae Preparata, the Radix Astragali, Caulis Spatholobi each 9.3, Olibanum (parched), Myrrha (parched), Bombyx Batryticatus, Radix Glycyrrhizae Preparata, Scolopendra each 3.1, Herba Asari 1.2, the Radix Paeoniae Alba 13.8.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98101748A CN1067571C (en) | 1998-05-04 | 1998-05-04 | Chinese medicine capsule for treating lumbar and cervical protrusion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98101748A CN1067571C (en) | 1998-05-04 | 1998-05-04 | Chinese medicine capsule for treating lumbar and cervical protrusion |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1234235A CN1234235A (en) | 1999-11-10 |
CN1067571C true CN1067571C (en) | 2001-06-27 |
Family
ID=5216907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98101748A Expired - Fee Related CN1067571C (en) | 1998-05-04 | 1998-05-04 | Chinese medicine capsule for treating lumbar and cervical protrusion |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1067571C (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001091771A2 (en) * | 2000-06-01 | 2001-12-06 | Theralife, Inc. | Compositions for treating back and leg discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
CN101190283B (en) * | 2006-11-20 | 2011-07-27 | 舒财 | Medicine for treating cervical vertebra disease |
CN101190268B (en) * | 2006-11-20 | 2011-07-27 | 舒财 | Compound medicine for treating cervical spondylosis |
CN101884716A (en) * | 2010-08-03 | 2010-11-17 | 代思友 | Medicinal liquor for treating lumbar disc herniation |
CN102225108B (en) * | 2011-05-24 | 2013-03-13 | 赵福祥 | Medicinal liquor for treating lumbago and protrusion of lumbar vertebral disc |
CN105596789A (en) * | 2014-11-03 | 2016-05-25 | 谢芳 | Bone paste |
-
1998
- 1998-05-04 CN CN98101748A patent/CN1067571C/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
《中医研究》1994年第7卷第1期 1994.1.1 李长庚等;"药垫治疗腰椎间盘突出症" * |
《中国农村学》1985年第5期 1985.1.1 张继昌;"腰腿痛1号治疗腰椎间盘突出症" * |
《中国农村学》1985年第5期 1985.1.1 张继昌;"腰腿痛1号治疗腰椎间盘突出症";《中医研究》1994年第7卷第1期 1994.1.1 李长庚等;"药垫治疗腰椎间盘突出症" * |
Also Published As
Publication number | Publication date |
---|---|
CN1234235A (en) | 1999-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102309644B (en) | Traditional Chinese medical composition for treating bone fracture | |
CN100423761C (en) | Chinese medicinal preparation for treating fracture, traumatic injury | |
CN100563690C (en) | A kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc | |
CN1365827A (en) | Exterior-applied medicine for treating osteopathy | |
CN103356877A (en) | Traditional Chinese medicine composition for treating orthopedic diseases | |
CN103784769A (en) | Chinese herbal preparation for treating orthopedic diseases | |
CN104398982A (en) | Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling | |
CN101703662B (en) | Oral Chinese medicament for treating hyperosteogeny | |
CN1067571C (en) | Chinese medicine capsule for treating lumbar and cervical protrusion | |
CN101040949B (en) | Medicine compound for creating rheumatism and rheumatoid arthritis and the preparing method and application | |
CN104922363A (en) | Traditional Chinese medicine composite for treating osteoproliferation | |
CN101912536A (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
CN101411799B (en) | Oral medicinal liquor for treating rheumatism and rheumatoid disease | |
CN1215875C (en) | Peroral Chinese medicine powder for treating bone fracture and its preparing process | |
CN1141173A (en) | Serial medicament for rehabilitation of spinal column | |
CN105688059A (en) | Traditional Chinese medicine preparation with folium artemisiae argyi for treating osteoproliferation through external application | |
CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
CN1055242C (en) | Chinese medicine for curing aseptic necrosis of head of femur | |
CN109432309A (en) | Chinese medicine composition, exterior-applied medical wine and its preparation method and application | |
CN116211946B (en) | Application of traditional Chinese medicine composition in preparation of medicine for promoting fracture healing | |
CN108888736B (en) | External-use bone reunion medicine and preparation method thereof | |
CN115814040B (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation thereof | |
CN102743531B (en) | Drug for treating cervical or lumbar diseases and preparation method thereof | |
CN102836346B (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
CN1320900C (en) | Bone erosion renewel pill |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |